Where to Inject Thymosin Alpha-1: Site Map
Thymosin Alpha-1 goes under the skin, 20 units at a time, five weekdays out of seven. That daily cadence changes how you should think about site selection and rotation. Here is the practical version: the four sites, the syringe math, the weekly map, and the one confusion worth clearing up before your first dose.

In this article
Key Takeaways
- Thymosin Alpha-1 is subcutaneous only. Four usable regions: the abdomen (staying two inches clear of the navel), the front or outer thigh, the upper outer glute, and the fat pad behind the deltoid.
- The prescribed dose is 20 units on a U-100 insulin syringe, which works out to 0.2 mL, taken once daily Monday through Friday. Weekends off is built into the schedule.
- No cycling is required. Ta1 is prescribed for continuous long-term use, which makes rotation discipline more important here than with a peptide you inject twice a week.
- Tolerability is the headline. Reactions are rare, and the ones patients mention are mild soreness at the site and, occasionally, mild flu-like symptoms.
- Thymosin Alpha-1 and TB-500 are unrelated molecules despite the shared family name. Ta1 is the only thymosin PeRx sells on its own; TB-500 appears only inside combination vials.
Thymosin Alpha-1 Injection Quick Facts
Route
Subcutaneous, under the skin (never into muscle)
Vial
5 mL at 5 mg/mL, ships ready to use
Dose
20 units (0.2 mL), once daily
Schedule
Monday through Friday, weekends off
Sites
Abdomen, thigh, upper outer glute, back of deltoid
Cycling
None required; continuous use as prescribed
Ta1 Goes Under the Skin
The answer to where to inject thymosin alpha-1 is any of four subcutaneous regions: the abdomen, the front or outer thigh, the upper outer glute, or the fat pad behind the deltoid. Under the skin, not into muscle. The dose is small, 20 units on an insulin syringe, and it repeats once a day from Monday through Friday. For the biology behind the molecule, where it comes from and what the clinical record actually shows, start with the thymosin alpha-1 guide. If you have never given yourself a subcutaneous shot at all, our walkthrough on injecting peptides covers the mechanics from hand-washing to sharps disposal. This page is the narrow version: sites, syringe math, a weekly rotation map, and the details that are specific to Ta1.
One thing to settle before you open the box. Your vial ships fully reconstituted and ready to use. There is no powder, no mixing step, and nothing to add. You uncap a syringe, draw to the 20-unit mark, and inject.
Where to Inject Thymosin Alpha-1: The Four Standard Sites
Every subcutaneous peptide uses the same four anatomical regions, and Ta1 is no exception. They differ in fat depth, in how easy they are to reach one-handed, and in how much usable surface area they give you for rotation.
1. Abdomen. Picture the band between your lowest ribs and your hip bones, minus a two-inch exclusion zone circling the navel. Most patients live here. The tissue is forgiving, you can see exactly what you are doing, and the surface area is large enough to keep rotating for weeks without repeating a spot. Work the soft area to the left and right of the belly button rather than the midline directly above or below it.
2. Front or outer thigh. The meaty middle third of the leg, on the front or the outside. Injecting the thigh while seated is easy to do one-handed, which is why it usually becomes site number two. Stay off the inner thigh, where vessels run closer to the surface, and leave a hand-width of clearance from both the knee and the hip crease.
3. Upper outer glute. The upper outer quadrant of the buttock, above and to the outside of where you would sit. Fat tends to be deepest here, so it is comfortable, but reaching it yourself takes a mirror or a willing partner. Patients on a five-day schedule often park one dose a week here purely to give the abdomen a rest day.
4. Back of the deltoid. The loose fat pad on the back of the upper arm, behind the deltoid muscle. This site depends entirely on your build. Pinch the area first: if you can gather half an inch of skin and fat, you have enough. If the skin snaps flat against muscle, pick a different region and stop thinking about this one.
Picking Your Primary Site
Nothing suggests that placing Ta1 in the thigh instead of the abdomen changes what the peptide does. It is absorbed into circulation from subcutaneous fat and reaches immune cells wherever they happen to be, so anatomy is a comfort question rather than a targeting one. Choose based on fat coverage, on how easily you can reach the spot, and on how much room the region gives you to rotate.
For most people that means the abdomen carries the bulk of the schedule, the thighs absorb two or three doses a week, and the glute comes in periodically. The deltoid is the one to skip unless you have genuine fat coverage there. Daily dosing rewards a plan you can actually keep track of, so pick two primary regions and one backup rather than trying to use all four evenly.
Practical Default
Abdomen and thigh as your two workhorses, glute as the periodic rest-day site, deltoid only if you can pinch a clear half inch of fat there.
The Dose and the Weekday Schedule
Thymosin Alpha-1 Protocol
Route
Subcutaneous injection
Vial
5 mL at 5 mg/mL
Dose
20 units (0.2 mL)
Frequency
Once daily, Monday through Friday
Cycling
None required
The units-versus-milliliters confusion trips up more first-time patients than site selection ever does. A U-100 insulin syringe is marked in units, and 100 of those units fill 1 mL. So the 20-unit line on the barrel is 0.2 mL of solution. You do not need to convert anything or do math at the counter. Draw to 20 and stop.
The arithmetic on the vial is worth knowing anyway. Five milliliters at 5 mg/mL holds 25 mg of peptide, and each 0.2 mL dose delivers 1 mg. That is 25 weekday doses per vial, or five working weeks. Read the barrel at eye level with the syringe upright rather than eyeballing it against the vial, because at this volume a small misread is a large fraction of the dose.
The Monday-through-Friday pattern is the prescribed schedule, not a workaround. Weekends off is already part of it. Ta1 requires no cycling and is intended for continuous long-term use as prescribed, so there is no washout week to plan for and no reason to interrupt the pattern on your own. Dose and frequency come from your prescription; nothing on this page replaces the label on your vial.
Building a Five-Day Rotation
Rotation matters more on a daily peptide than on one you inject twice a week, for the obvious reason: you are asking your tissue to absorb roughly twenty injections a month instead of eight. Hitting the same square inch repeatedly produces small firm nodules, occasional bruising, and thickened tissue that absorbs the next dose less predictably. None of that is dangerous. All of it is avoidable.
The working rule is a finger-width, about one inch, from wherever the last needle went. That is easy to satisfy inside a single region. Split the abdomen into quadrants on each side of the navel and you have eight distinct spots before you have to leave the area at all.
A five-day map that most patients can hold in their head: Monday upper right abdomen, Tuesday upper left abdomen, Wednesday right thigh, Thursday left thigh, Friday lower abdomen or glute. The following week, run the same order but shift each spot a finger-width from where it landed last time. Two weeks of that and no square inch has taken more than one needle.
Low-Tech Tracking
If you cannot remember Thursday by Friday, a fingernail indent next to the last spot or a dot on a phone note is enough. Tracking beats remembering, especially on a five-day-a-week schedule.
Ta1 Is Not TB-500
This is the single most common mix-up in the thymosin category, and it is worth ninety seconds of your time. Thymosin Alpha-1 and TB-500 share a family name and almost nothing else. They are different molecules from different branches of the thymosin family, they are used for different reasons, and they are not interchangeable at any dose.
| Thymosin Alpha-1 | TB-500 (Thymosin Beta-4) | |
|---|---|---|
| What it is | A 28-amino-acid thymic peptide | A synthetic fragment of thymosin beta-4, a separate protein |
| Family | Alpha branch of the thymosins | Beta branch; a shared word, not a shared mechanism |
| Why patients use it | Immune support | Tissue repair and recovery support |
| How PeRx supplies it | Its own vial, the only thymosin sold on its own | Only inside combination vials, never standalone |
| Route | Subcutaneous | Subcutaneous |
| Injection sites | The same four regions | The same four regions |
What it is
- Thymosin Alpha-1
- A 28-amino-acid thymic peptide
- TB-500 (Thymosin Beta-4)
- A synthetic fragment of thymosin beta-4, a separate protein
Family
- Thymosin Alpha-1
- Alpha branch of the thymosins
- TB-500 (Thymosin Beta-4)
- Beta branch; a shared word, not a shared mechanism
Why patients use it
- Thymosin Alpha-1
- Immune support
- TB-500 (Thymosin Beta-4)
- Tissue repair and recovery support
How PeRx supplies it
- Thymosin Alpha-1
- Its own vial, the only thymosin sold on its own
- TB-500 (Thymosin Beta-4)
- Only inside combination vials, never standalone
Route
- Thymosin Alpha-1
- Subcutaneous
- TB-500 (Thymosin Beta-4)
- Subcutaneous
Injection sites
- Thymosin Alpha-1
- The same four regions
- TB-500 (Thymosin Beta-4)
- The same four regions
The practical upshot for anyone reading a protocol they found elsewhere: a dosing schedule written for TB-500 tells you nothing about Ta1. If you want the tissue-repair side of the catalog, that lives in the combination products, and the BPC-157 and TB-500 guide explains how those are put together. Ta1 stands alone, and it is the only thymosin that does.
Why Ta1 Is Easy to Tolerate
Tolerability is the quiet reason this peptide reads well on paper. Side effects are rare, which matters when the schedule asks you to inject five days a week for months at a stretch.
What does show up is minor. Mild discomfort at the injection site is the common one, and it is usually technique-driven: cold solution straight from the fridge, a fast plunger, or a needle that has already been through a stopper once. Rare mild flu-like symptoms have also been reported. Neither is a reason to stop on your own, and neither is what most patients experience.
Two habits cut site discomfort further. Let the syringe sit at room temperature for a minute or two after drawing rather than injecting straight-from-the-fridge solution, and push the plunger slowly enough that the injection takes several seconds rather than one. If you are weighing what is normal against what is not across peptides generally, the peptide side effects guide sorts the routine from the notable.
Storage, Handling, and Travel
PeRx ships Thymosin Alpha-1 fully reconstituted and ready to use. Store it refrigerated at 36-46°F (2-8°C), keep the vial upright, and do not freeze it. Put it back in the refrigerator right after you draw rather than leaving it on the counter through breakfast.
Look at the solution every single time before you draw. It should be clear. Particles, cloudiness, or a color shift all mean set it aside and contact your provider instead of injecting it. Since one vial covers five weeks of weekday dosing, you will be inspecting the same vial a lot of mornings, and that is exactly the situation where the habit slips.
Travel is straightforward. An insulated bag with a small ice pack handles anything longer than a couple of hours. Keep the vial in your carry-on, never in checked luggage, and bring the prescription label or a screenshot of your PeRx order in case anyone asks at security. A five-day-a-week schedule means most trips will overlap at least a few doses, so pack the syringes too.
Precautions and When to Call
Ta1 is an immune-modulating peptide, and that is the source of its one real precaution. Transplant recipients and anyone taking immunosuppressant medication need caution here, because deliberately nudging immune activity in someone whose treatment plan depends on suppressing it is a genuine conflict. Flag either situation during screening rather than after your first vial arrives.
Call 911
Swelling of the face, throat, or tongue, difficulty breathing, rapid heartbeat, severe dizziness, or a fever above 103°F / 39.4°C are emergencies. Call 911. Do not wait to see whether they settle down.
Short of that, the ordinary stuff is ordinary. Redness that fades within a day, a small bruise, mild tenderness at a spot you have used recently: all routine, all handled by moving an inch and slowing the plunger down. If a site stays firm or sore for more than a couple of days, stop using that region and rotate elsewhere while it settles. If it has not cleared after a few days, or if a mild rash or localized hives show up, contact the care team.
Thymosin Alpha-1: Common Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Is Thymosin Alpha-1 FDA Approved? Not in the US
Not in the United States. But Thymosin Alpha-1 is approved for medical use in over 35 countries under the brand name Zadaxin, primarily for hepatitis B and C treatment and as an immune system modulator. It has FDA Orphan Drug designation for hepatocellular carcinoma. It is one of the most clinically validated peptides in existence, everywhere except the US.
Peptides for Autoimmune Patients: Cautions
Autoimmune disease makes every immune-active therapy a shared decision. A physician-reviewed guide to Thymosin Alpha-1 as an immunomodulator (not a booster), what to tell your rheumatologist, and where caution is non-negotiable.
Boulder Peptide Therapy: 2026 Local Guide
A plain guide to peptide therapy in Boulder: what it costs across local clinics, mobile services, and telehealth, and who tends to use it here. Plus how pharmaceutical-grade peptides reach any Boulder County address without a clinic visit.
Ready to get started?
Pharmaceutical-grade Thymosin Alpha-1, prescribed by a licensed provider and shipped to your door fully reconstituted and ready to use.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.